Bone cancer survival rates can widely differ and is dependent on many variables that a universal figure that applies to all cases is simply not available. Each cancer case is unique so statistical data on bone cancer survival rate should not be seen as a definite determinant of surviving a specific cancer. How is a bone cancer survival rate determined? The number one basis for this is the staging of the primary cancer. Cancer stages in bone cancer are determined by the size of the tumor, its spread to the lymph nodes, and its metastatic status. Early cancer stages like stage 1 and stage 2 bone cancer are deemed highly treatable with many interventions available to patients. This is the same with the case of other cancers where early detection and diagnosis is the key to a better survival rate of bone cancer.
The survival rate for bone cancer is much lower when it is in its metastatic stage. This is usually identified with late stage 4 cancer which means that the cancer is spreading all over the body. At this level, the cancer is harder to contain and can often imply that the proper management of the disease is the remaining sensible course of action. This includes giving relief to the symptoms of the cancer such as pain and the repair of damaged bones due to the onslaught of the cancer.
The survival rate between a primary and secondary bone cancer differs a lot. To better understand this it is important for you to realize the nature of both cancers. Primary bone cancer is caused by mutated bone cells. The cancer in this case started within the structure of the bone itself. Secondary cancers in the bone on the other hand are those cancers that came from the other organs in the body such as the lung that eventually spread to the bones via the lymphatic system or through the blood stream. Cancer only spreads on its very last stages. A breast cancer metastasis to the bone has only a 15% survival rate. A primary bone cancer like in the case of chondrosarcoma has a relative 5 year survival rate of 80%, a very good rate compared to the rate of the metastasized breast cancer. The metastatic bone cancer survival rate is innately much lower because the cancer is aggressively spreading all over the body.
In the case of bone marrow cancer, the outlook can be more positive. Multiple myeloma or leukemia (general classifications of bone marrow cancer) is highly treatable and some types of these cancers are not as aggressive (some are even asymptomatic). Bone marrow cancer survival rate is very positive that some kids diagnosed with leukemia live long and productive lives with many of them reaching adulthood.
Prostate cancer metastasis to bone on the other hand has poorer prognosis than bone marrow cancer. Prostate cancer patients are expected to survive only a year after the disease’s spread to the bones is detected. Prostate bone cancer metastasis is a last stage prostate cancer that often spreads to the lungs and the bones. Treatment options for a spreading prostate cancer is very limited resulting to a 12-month median survival rate.
So to sum it up, 1- The survival rate of the bone cancer will depend on the actual extent of the cancer spread and on the responsiveness of the patient to medication and treatment. 2- The higher the patient’s bone cancer stage is, the lower the life expectancy for the patient it becomes.
Stage I: The cancer is localized
Stage II: It has spread to nearby regions
Stage III: It has metastasized to various parts of the body
Stage IV: The disease is out of control; it is present all over the body.
Obviously stage 4 bone cancer survival rate is much less.